Navigation Links
European Chemical Market: Strategic Assessments of Leading Suppliers
Date:10/5/2011

NEW YORK, Oct. 5, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

European Chemical Market: Strategic Assessments of Leading Suppliers

http://www.reportlinker.com/p0651441/European-Chemical-Market-Strategic-Assessments-of-Leading-Suppliers.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Over-The-Counter_Drug

This report provides chemical industry executives with strategically significant competitor information, analysis and insight on the European market players, crucial to the development and implementation of effective business, marketing and R&D programs.

The companies analyzed in this report include BASF, Bayer, BP, Dow, DuPont, ExxonMobil, Formosa, ICI, INEOS, LyondellBasell, Mitsubishi Chemical, SABIC, Shell, Sinopec, and Total.

Report Objectives:

• To establish a comprehensive, factual, annually updated and cost-effective information base on performance, capabilities, goals and strategies of the leading players in the European chemical market.

• To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis the leading competitors.

• To assist potential market entrants in evaluating prospective acquisition and joint venture candidates.

• To complement the organizations' internal competitor information gathering efforts with strategic analysis, data interpretation and insight.

This report is based on a combination of primary and secondary information sources, including Venture Planning Group's proprietary database developed during the firm's continuous monitoring of the chemical industry, as well as over 100 syndicated multi-client studies and numerous proprietary single-client assignments. The database contains information on major chemical companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the leading suppliers product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.

Contains 828 pages and 127 tables

Table of Contents

BASF

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Bayer

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

BP

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Dow

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic DirectionDuPont

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

ExxonMobil

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Formosa

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

ICI

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic DirectionINEOS

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

LyondellBasell

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Mitsubishi Chemical

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

SABIC

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic DirectionShell

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Sinopec

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

Total

Executive Summary

Ownership

Business Evolution

Organization and Management

Major Facilities

Product Portfolio and Technological Know-How

Marketing Capabilities

Financial Analysis

Strengths and Weaknesses

Strategic Direction

List of Tables

Table BF-1: BASF Sales and Operating Profit Growth

Table BF-2: BASF by Business Segment

Table BF-3: BASF Sales Growth by Business Segment

Table BF-4: BASF Operating Profit and Margins by Business Segment

Table BF-5: BASF Chemicals Sales by Division

Table BF-6: BASF Plastics Sales by Division

Table BF-7: BASF Performance Products Sales by Division

Table BF-8: BASF Agricultural Products and Nutrition Sales by Division

Table BF-9: BASF Sales by Geographic Region and Country

Table BF-10: BASF Sales Growth by Geographic Region and CountryTable BR-1: Bayer Sales and Operating Profit Growth

Table BR-2: Bayer Sales by Business Segment

Table BR-3: Bayer Sales Growth by Business Segment

Table BR-4: Bayer Sales by Geographic Region

Table BR-5: Bayer Sales Growth by Geographic Region

Table BR-6: Bayer Material Science Sales by Geographic Region

Table BR-7: Bayer Material Science Sales Growth by Geographic Region

Table BR-8: Bayer Material Science Sales by Product Category

Table BR-9: Bayer Material Science Sales Growth by Geographic Region

Table BR-10: Bayer Systems Sales by Geographic Region

Table BR-11: Bayer Systems Sales Growth by Geographic Region

Table BR-12: Bayer Systems Sales by Product Category

Table BR-13: Bayer Systems Sales Growth by Product Category

Table BR-14: Bayer Materials Sales by Geographic Region

Table BR-15: Bayer Materials Sales Growth by Geographic Region

Table BR-16: Bayer Materials Sales by Product Category

Table BR-17: Bayer Material Sales Growth by Product Category

Table BP-1: BP Sales by Business

Table BP-2: BP Sales Growth by Business

Table BP-3: BP Sales and Operating Profit Growth

Table BP-4: BP Sales by Geographic Region

Table DC-1: Dow Sales and Operating Profit Growth

Table DC-2: Dow Sales by Operating Segment

Table DC-3: Dow Sales Growth by Operating Segment

Table DC-4: Dow Sales by Geographic Region

Table DC-5: Dow Sales Growth by Geographic Region

Table DP-1: DuPont Sales and Operating Profit Growth

Table DP-2: DuPont Sales by Industry Segment

Table DP-3: DuPont Sales Growth by Industry Segment

Table DP-4: DuPont Operating Profit and Margins by Industry Segment

Table DP-5: DuPont Sales by Geographic Region

Table DP-6: DuPont Sales Growth by Geographic Region

Table DP-7: DuPont Sales Growth by Country

Table EM-1: ExxonMobil Sales and Operating Profit Growth

Table EM-2: ExxonMobil Operating Profit Growth by Business

Table EM-3: ExxonMobil Chemicals Profit Growth by Geographic Region

Table EM-4: ExxonMobil Worldwide Chemicals Production by Product Line

Table EM-5: ExxonMobil Worldwide Chemicals Production Growth by Product Line

Table FO-1: Formosa Sales by Operating Company

Table FO-2: Formosa Profit and Margins by Operating Company

Table FO-3: Formosa Sales Growth by Operating Company

Table FO-4: Formosa Profit Growth by Operating Company

Table FO-5: Formosa Production of Selected Products

Table IC-1: ICI Sales by Business Sector

Table IC-2: ICI Operating Profit by Business Sector

Table IC-3: ICI Sales and Operating Profit GrowthTable IC-4: ICI Sales Growth by Business Sector

Table IC-5: ICI Operating Profit Growth by Business Sector

Table IC-6: ICI Sales by Geographic Region

Table IC-7: ICI Paint Sales by Geographic Region

Table IC-8: ICI National Starch Sales by Geographic Region

Table IC-9: ICI Performance Specialties Sales by Geographic Region

Table IC-10: ICI Regional and Industrial Sales by Geographic Region

Table IC-11: ICI National Starch Sales by Business Group

Table IC-12: ICI Performance Specialties Sales by Business Unit

Table IN-1: INEOS Sales and Operating Profit Growth

Table IN-2: INEOS Sales by Business Segment

Table IN-3: INEOS Sales Growth by Business Segment

Table IN-4: INEOS Sales by Geographic Region

Table IN-5: INEOS Sales Growth Geographic Region

Table LB-1: LyondellBasell Sales and Operating Profit Growth

Table LB-2: LyondellBasell Sales by Business Segment

Table LB-3: LyondellBasell Sales Growth by Business Segment

Table LB-4: LyondellBasell Sales by Geographic Region

Table LB-5: LyondellBasell Sales Growth Geographic Region

Table MI-1: Mitsubishi Sales by Industry Segment

Table MI-2: Mitsubishi Operating Profit and Margins by Industry Segment

Table MI-3: Mitsubishi Sales and Operating Profit Growth

Table MI-4: Mitsubishi Sales by Geographic Region

Table MI-5: Mitsubishi Chemicals Sales Growth by Industry Segment

Table SA-1: Sabic Sales and Operating Profit Growth

Table SA-2: Sabic Sales by Business Segment

Table SA-3: Sabic Sales Growth by Business Segment

Table SA-4: Sabic Sales by Geographic Region

Table SA-5: Sabic Sales Growth Geographic Region

Table SH-1: Shell Revenue by Industry Segment

Table SH-2: Shell Revenue Growth by Industry Segment

Table SH-3: Shell Chemicals Sales by Geographic Region

Table SH-4: Shell Chemicals Sales Growth by Geographic Region

Table SH-5: Shell Chemicals Sales Growth by Product Category

Table SI-1: Sinopec Sales and Operating Profit Growth

Table S I-2: Sinopec Sales by Operating Segment

Table SI-3: Sinopec Sales Growth by Operating Segment

Table SI-4: Sinopec Chemicals Production Growth by Product Category

Table SI-5: Sinopec Operating Profit and Margins by Business Segment

Table SI-6: Sinopec Operating Profit Growth by Business Segment

Table TO-1: Total Sales by Business Segment

Table TO-2: Total Sales Growth by Business Segment

Table TO-3: Total Operating Profit and Margins by Business Segment

Table TO-4: Total Operating Profit Growth by Business Segment

Table TO-5: Total Chemicals Sales and Operating Profit Growth

Table TO-6: Total Petrochemicals and Plastics Capacity by Product LineTable TO-7: Total Petrochemicals and Plastics Production Capacity Growth by Product Line

To order this report:

Over-The-Counter Drug Industry: European Chemical Market: Strategic Assessments of Leading Suppliers

Over-The-Counter Drug Business News

More  Industry Analysis and Insights

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartWare Announces Presentation of Clinical Data at the 25th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting in Lisbon
2. NVA237 Filed in Europe and Positive Phase III Data at European Respiratory Society Congress
3. Elsevier Launches European Journal of Cancer iPad Edition
4. Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver Presented at European Multidisciplinary Cancer Congress
5. Optimer Pharmaceuticals and Astellas Receive Positive Opinion from CHMP for European Approval of DIFICID™
6. Amgen Highlights Data to be Presented at 2011 European Multidisciplinary Cancer Congress
7. Pinnacle Biologics Appoints ALKOPHARMA SA Its Exclusive Distributor For PDT (Photodynamic Therapy), in Select European Countries, Middle East And South East Asian Territories
8. Lexicon Presents LX4211 Clinical Data at European Association for the Study of Diabetes Annual Meeting
9. Intarcia Announces Presentations of Three Clinical Abstracts at the 47th Annual Meeting of the European Association for the Study of Diabetes
10. European Fine Chemicals Group Ratifies FDAs Proposed Generic Drug User Fees Act (GDUFA)
11. Angioslide Announces the European Launch of New 300 mm Long Device Allowing Treatment of Entire Superficial Femoral Artery(SFA) with One Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... Italy , April 27, 2016 ... linear accelerator (MR-linac) platform will be the focal point ... meeting of the European Society for Radiotherapy & Oncology, ... Elekta,s MR-linac integrates a state-of-the-art radiotherapy system and a ... physician to clearly see the patient,s anatomy in real ...
(Date:4/27/2016)... Shire plc (LSE: SHP, NASDAQ: ... Financial Officer, will present at the Deutsche Bank 41st Annual ... on Wednesday, May 04, 2016, 10:00 am EDT (15:00 BST). ... the Presentations and Webcasts section of Shire,s Investor website at ... be available on this same website for approximately 90 days. ...
(Date:4/27/2016)... April 27, 2016 At the ... launch of a Phase 2 clinical study of its ... patients undergoing cochlear implantation (CI) surgery. This large, placebo-controlled, ... Germany and France ... ear at the time of surgery. "Despite advances in ...
Breaking Medicine Technology:
(Date:4/30/2016)... , ... April 30, 2016 , ... “Aging well is a challenge for all of us, but there are things ... Parul T. Kohli . “Research is showing more and more that there are simple, yet ... and disability as we age.” Top priorities Dr. Kohli’s recommends for her patients include;, ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Footwear Foundation, the national charitable foundation serving the footwear industry, has broken all ... representing more than 130 companies across 23 states during the months of April ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... the heart of our nation’s productivity, stability, even security. Most importantly, employees are ... organizations. , Then why are American workers so unhappy? , Just under half ...
(Date:4/29/2016)... Fla. (PRWEB) , ... April 29, 2016 , ... ... Hospital surgeon reveals that infants born with severe congenital diaphragmatic hernia have better ... is born with congenital diaphragmatic hernia (CDH)—a condition where the diaphragm fails to ...
(Date:4/29/2016)... ... 29, 2016 , ... The Gluten-Free Certification Program (GFCP), in ... the launch of the GFCP Scoop in response to consumer demand ... the GFCP Scoop site is to keep the gluten-free community updated ...
Breaking Medicine News(10 mins):